Business of Medicine
Opinion
Sharpening the saw
I write this reminder every couple of years because it’s so easy to lose sight of the overall landscape among the pressures of our daily routines...
Latest News
Rheumatologists target prior authorization, Stark Law as barriers to competition
The ACR responds to HHS’ request for information.
Feature
Congress extends CHIP, funds opioid crisis response following temporary shutdown
Bill also addressed controversial Medicare payment panel.
Feature
Bipartisan Senate budget deal boosts health programs
As usual, its fate is uncertain in the House.
Conference Coverage
MedPAC: Medicare hospital readmissions program is working
WASHINGTON – Not everyone was convinced by MedPAC staff analysis.
Conference Coverage
MedPAC mulls boost to payments for E&M visits
WASHINGTON – The commissioners debated whether the pay boost would make a difference.
Opinion
Preventive health: Getting rid of the middleman (uh-oh, that’s us!)
Preventive health is, frankly, really difficult.
Feature
Expert advice for the corporate titans taking on health care
Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. want to disrupt health care.
Latest News
Health care gets little attention in State of the Union address
It’s anyone’s guess as to how Mr. Trump might lower drug costs.
Feature
Alex Azar confirmed as HHS Secretary
Democrats on the Senate Finance Committee challenged Mr. Azar on drug prices and other issues.
Feature
Doctors to Congress: Keep Part B drug payments out of MIPS adjustment
Certain specialists stand to lose significant Medicare pay under the current policy.